000 01688 a2200469 4500
005 20250515153242.0
264 0 _c20090608
008 200906s 0 0 eng d
022 _a1756-9966
024 7 _a10.1186/1756-9966-27-87
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCheng, Zhi Y
245 0 0 _aPTEN and rapamycin inhibiting the growth of K562 cells through regulating mTOR signaling pathway.
_h[electronic resource]
260 _bJournal of experimental & clinical cancer research : CR
_cDec 2008
300 _a87 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Growth Processes
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCyclin D1
_xbiosynthesis
650 0 4 _aCyclin-Dependent Kinase Inhibitor p27
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aIntracellular Signaling Peptides and Proteins
_xgenetics
650 0 4 _aK562 Cells
650 0 4 _aPTEN Phosphohydrolase
_xbiosynthesis
650 0 4 _aProtein Kinases
_xbiosynthesis
650 0 4 _aRNA, Messenger
_xbiosynthesis
650 0 4 _aSignal Transduction
650 0 4 _aSirolimus
_xmetabolism
650 0 4 _aTOR Serine-Threonine Kinases
650 0 4 _aTransfection
700 1 _aGuo, Xiao L
700 1 _aYang, Xiao Y
700 1 _aNiu, Zhi Y
700 1 _aLi, Shi H
700 1 _aWang, Su Y
700 1 _aChen, Hao
700 1 _aPan, Ling
773 0 _tJournal of experimental & clinical cancer research : CR
_gvol. 27
_gp. 87
856 4 0 _uhttps://doi.org/10.1186/1756-9966-27-87
_zAvailable from publisher's website
999 _c18565922
_d18565922